Company CEO to present on October 28, 2014 JERUSALEM , October 24, 2014 /PRNewswire/ --
Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company's CEO, Nadav Kidron will present at FireRock Capital's Micro-Cap Conference.
Third Quarter Highlights
4th consecutive quarter of growth in commercial loans
Core deposits increased 19% from the prior quarter
Net interest margin increased 21 basis points from the prior quarter
Exit from residential mortgage business completed
All remaining OREO at the Bank sold for a gain
Consolidated OREO reduction of 78% from the prior quarter; remaining exposure isolated to PMAR
COSTA MESA, Calif., Oct.
Sign-up for PENFORD CORP. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of the Board of Directors of Penford Corporation (PENX) in Relation to the Proposed Sale of the Company to Ingredion Inc. investment picks
Polaris Industries Inc. (NYSE: PII) today announced the declaration of a
regular quarterly $0.48 per share cash dividend payable on December 15,
2014 to shareholders of record at the close of business on December 1,
a leading direct marketing provider with expertise in the retail,
healthcare, financial, and insurance verticals, announced today it will
offer unique expert insights on direct mail and digital integration
during its “Take Ten” Speaker Series at the Direct
Marketing Association’s (DMA) DMA2014
Conference & Exhibition .
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.